Cardiovascular Systems

Selected news for the company - Cardiovascular Systems, collected since 10/2017. This company shares news with Zacks Investment Research, Tactile Systems Technology, Medtronic, SVB Leerink and dozens of others.

Please provide a valid email address.

Selected Headlines

Date Headline (link) Source Relevant Snippet
1/19/2022 Cardiovascular Systems, Inc. (NASDAQ:CSII) Given Consensus Recommendation of “Buy” by Brokerages - American Banking News American Banking News ... company. The average twelve-month price objective among brokerages that have issued a report on the stock in the last year is $37.40.A number of brokerages recently weighed in on CSII. Guggenheim downgraded Cardiovascular Systems from a “buy” rating to a “neutral” rating in a research note on Wednesday, November 10th. Zacks Investment Research raised Cardiovascular Systems from a “sell” rating to a “hold” rating ...
1/18/2022 AlphaCrest Capital Management LLC Buys Shares of 70,200 Cardiovascular Systems, Inc. (NASDAQ:CSII) Dakota Financial News AlphaCrest Capital Management LLC bought a new stake in Cardiovascular Systems, Inc. (NASDAQ:CSII) during the 3rd quarter, Holdings Channel.com reports. The firm bought 70,200 shares of the medical device company’s stock, valued at approximately $2,305,000.Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. First Horizon Advisors Inc. bought a new stake in Cardiovascular Systems in the 3rd ...
1/18/2022 AlphaCrest Capital Management LLC Takes $2.31 Million Position in Cardiovascular Systems, Inc. (NASDAQ:CSII) Mayfield Recorder AlphaCrest Capital Management LLC bought a new stake in Cardiovascular Systems, Inc. (NASDAQ:CSII) during the third quarter, Holdings Channel.com reports. The fund bought 70,200 shares of the medical device company’s stock, valued at approximately $2,305,000.Several other hedge funds and other institutional investors also recently bought and sold shares of the stock. First Horizon Advisors Inc. purchased a new position in Cardiovascular Systems during the 3rd quarter worth ...
1/18/2022 Analyzing PAVmed (NASDAQ:PAVM) and Cardiovascular Systems (NASDAQ:CSII) - Ticker Report Ticker Report PAVmed ( NASDAQ:PAVM ) and Cardiovascular Systems ( NASDAQ:CSII ) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, dividends, valuation, profitability, risk, analyst recommendations and institutional ownership.ProfitabilityGet PAVmed alerts: This table compares PAVmed and Cardiovascular Systems’ net margins, return on equity and return on assets.Net Margins Return on Equity Return on ...
1/18/2022 Cardiovascular Systems, Inc. (NASDAQ:CSII) Short Interest Update baseballnewssource.com ... company’s stock are sold short.A number of hedge funds and other institutional investors have recently bought and sold shares of CSII. First Horizon Advisors Inc. acquired a new stake in shares of Cardiovascular Systems in the 3rd quarter worth approximately $46,000. Profund Advisors LLC acquired a new stake in shares of Cardiovascular Systems in the 2nd quarter worth approximately $208,000. Teacher Retirement System of Texas lifted its stake ...
1/16/2022 Cardiovascular Systems (NASDAQ:CSII) Shares Gap Up to $18.07 The Markets Daily Shares of Cardiovascular Systems , Inc. (NASDAQ:CSII) gapped up before the market opened on Friday . The stock had previously closed at $18.07, but opened at $18.55. Cardiovascular Systems shares last traded at $20.59, with a volume of 5,752 shares traded.CSII has been the subject of several research reports. Guggenheim downgraded shares of Cardiovascular Systems from a “buy” rating to a “neutral” rating in a research report on ...
1/16/2022 Cardiovascular Systems (NASDAQ:CSII) Shares Gap Up to $18.07 Dakota Financial News Shares of Cardiovascular Systems , Inc. (NASDAQ:CSII) gapped up before the market opened on Friday . The stock had previously closed at $18.07, but opened at $18.55. Cardiovascular Systems shares last traded at $20.59, with a volume of 5,752 shares trading hands.Several research firms have issued reports on CSII. Oppenheimer lowered their target price on shares of Cardiovascular Systems from $48.00 to $40.00 and set an “outperform” rating on ...
1/16/2022 Cardiovascular Systems, Inc. (NASDAQ:CSII) Expected to Post Quarterly Sales of $62.71 Million - WKRB News wkrb13.com Equities analysts expect that Cardiovascular Systems , Inc. (NASDAQ:CSII) will report $62.71 million in sales for the current quarter, Zacks reports. Six analysts have issued estimates for Cardiovascular Systems ’ earnings, with the lowest sales estimate coming in at $61.30 million and the highest estimate coming in at $66.30 million. Cardiovascular Systems posted sales of $64.17 million in the same quarter last year, which suggests a negative year-over-year ...
1/15/2022 Cardiovascular Systems (NASDAQ:CSII) Lifted to Hold at Zacks Investment Research baseballnewssource.com Zacks Investment Research upgraded shares of Cardiovascular Systems (NASDAQ:CSII) from a sell rating to a hold rating in a research note published on Tuesday, Zacks.com reports. They currently have $19.00 price objective on the medical device company’s stock.According to Zacks, “Cardiovascular Systems’ coronary franchise registered strong performance globally on continued strength in Japan and growing uptake of coronary OAS in Europe during the first quarter of ...
1/15/2022 Cardiovascular Systems (NASDAQ:CSII) Lifted to Hold at Zacks Investment Research - The Cerbat Gem thecerbatgem.com Zacks Investment Research upgraded shares of Cardiovascular Systems (NASDAQ:CSII) from a sell rating to a hold rating in a research report sent to investors on Tuesday, Zacks.com reports. They currently have $19.00 price target on the medical device company’s stock.According to Zacks, “Cardiovascular Systems’ coronary franchise registered strong performance globally on continued strength in Japan and growing uptake of coronary OAS in Europe during the first ...
1/11/2022 Heart-Saving Drone; Drug-Associated Myocarditis; CAR-T Therapy for HF? | MedPage Today medpagetoday.com ... meta-analysis found. ( Journal of the American Heart Association )The American Academy of Neurology issues a statement on how to approach emergency medical decision-making for acute ischemic stroke patients. ( Neurology )FDA alerted to Cardiovascular Systems Inc.'s class I recall of the Wirion embolic protection device used during atherectomy, stemming from problems with filter breakage during retrieval.China finally approves transcatheter aortic valve replacement using a Medtronic self-expanding ...
1/11/2022 Cardiovascular Systems (NASDAQ:CSII) Upgraded to Hold by Zacks Investment Research The Markets Daily ... in the reported quarter. The company certified 80 new coronary users outside the United States. The company also plans to initiate the full commercial launch of the Viper cross peripheral catheter in Q2. However, Cardiovascular Systems underperformed its industry in the past three months. The company’s fiscal first-quarter loss was wider than the consensus mark. The company’s revenues too lagged the Zacks Consensus Estimate. Peripheral revenues registered ...
1/11/2022 Cardiovascular Systems recalls embolic protection devices that may break off during procedures FierceBiotech Less than a year after debuting its Wirion embolic protection system, Cardiovascular Systems is recalling all of the devices manufactured and distributed between January and November 2021.The Wirion system includes a filter inserted through a blood vessel in the leg via a catheter. The filter catches and removes any blood clots or debris floating in the bloodstream before they reach vital organs during an atherectomy procedure to remove plaque ...
1/11/2022 PAVmed (NASDAQ:PAVM) vs. Cardiovascular Systems (NASDAQ:CSII) Head-To-Head Review - Stock Observer thestockobserver.com PAVmed ( NASDAQ:PAVM ) and Cardiovascular Systems ( NASDAQ:CSII ) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their risk, dividends, earnings, profitability, valuation, analyst recommendations and institutional ownership.ProfitabilityGet PAVmed alerts: This table compares PAVmed and Cardiovascular Systems’ net margins, return on equity and return on assets.Net Margins Return on Equity Return on ...
1/11/2022 Cardiovascular Systems Recalls Wirion Embolic Protection Device Medscape Cardiovascular Systems Inc (CSI) has recalled its Wirion embolic protection device (Wirion) due to complaints that the filter may break during retrieval, according to a notice posted on the US Food and Drug Administration (FDA) website.The Wirion system is used to hold and remove debris or blood clots from the lower limbs during atherectomy procedures.“Under certain circumstances, such as when the filter basket is too full, the filter ...
1/11/2022 Cardiovascular Systems Recalls Wirion Embolic Protection Device truemedian.com Cardiovascular Systems Inc (CSI) has recalled its Wirion embolic protection device (Wirion) due to complaints that the filter may break during retrieval, according to a notice posted on the US Food and Drug Administration (FDA) website.The Wirion system is used to hold and remove debris or blood clots from the lower limbs during atherectomy procedures.“Under certain circumstances, such as when the filter basket is too full, the filter ...
1/10/2022 Cardiovascular Systems, Inc. (NASDAQ:CSII) Shares Sold by Victory Capital Management Inc. - Mayfield Recorder Mayfield Recorder Victory Capital Management Inc. lessened its holdings in shares of Cardiovascular Systems , Inc. (NASDAQ:CSII) by 6.8% during the 3rd quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 57,031 shares of the medical device company’s stock after selling 4,192 shares during the period. Victory Capital Management Inc.’s holdings in Cardiovascular Systems were worth $1,872,000 at the end of the most recent ...
1/9/2022 Cardiovascular Systems (NASDAQ:CSII) Reaches New 52-Week Low at $18.04 - Slater Sentinel slatersentinel.com ... last traded at $18.04, with a volume of 3250 shares traded. The stock had previously closed at $18.72.CSII has been the topic of several research analyst reports. Zacks Investment Research lowered shares of Cardiovascular Systems from a “hold” rating to a “strong sell” rating and set a $25.00 price target on the stock. in a research note on Friday, November 12th. Needham & Company LLC lowered shares of ...
1/7/2022 In the Know: Healthcare News for January 10, 2022 medicalalley.org NewsTags: 3M, Abbott, Allina Health, Amplifon, Be The Match, Bio-Techne, Boston Scientific, Cardiovascular Systems , Coloplast, Cretex, DiaMedica, GE Healthcare, Hillrom, In the Know, Inspire Medical Systems, Medtronic, Metavention, Miromatrix, Neovasc, Olympus, Philips, Relievant Medsystems, Smiths Medical, Starkey, Steris, Stryker, Switchback Medical, The Good ClinicWe will elevate Medical Alley as The Global Epicenter of Health Innovation and Care® ...
1/2/2022 Cardiovascular Systems, Inc. (NASDAQ:CSII) Stock Position Boosted by State of New Jersey Common Pension Fund D Daily Political Cardiovascular Systems, Inc. (NASDAQ:CSII) Stock Position Boosted by State of New Jersey Common Pension Fund D Posted by Stacy Sanders on Jan 2nd, 2022 Share on StocktwitsState of New Jersey Common Pension Fund D boosted its stake in Cardiovascular Systems , Inc. (NASDAQ:CSII) by 10.1% in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 72,770 shares of the ...